Adrenergic receptors and cyclic AMP in the regulation of human adipose tissue lipolysis.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000242:Cyclic AMP / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology; D004837:Epinephrine / Q000008:administration & dosage / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D013006:Growth Hormone / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000008:administration & dosage* / Q000494:pharmacology*; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects*; D010646:Phentolamine / Q000008:administration & dosage / Q000494:pharmacology; D010902:Pituitary Gland; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology*; D013972:Thyrotropin / Q000494:pharmacology
D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D003907:Dexamethasone; D013972:Thyrotropin; D013006:Growth Hormone; D005934:Glucagon; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D007545:Isoproterenol; D004837:Epinephrine; D010646:Phentolamine